Brief: Bioadaptives Says Successful Completion Of Dosage Trials For Its Innovative Weight Loss Product, Zeranovia
13/03/2025 14:56
March 13 (Reuters) - BioAdaptives Inc BDPT.PK: BIOADAPTIVES INC: SUCCESSFUL COMPLETION OF DOSAGE TRIALS FOR ITS INNOVATIVE WEIGHT LOSS PRODUCT, ZERANOVIA BIOADAPTIVES INC: TRIAL DEMONSTRATED SIGNIFICANT WEIGHT LOSS RESULTS WITH MINIMAL SIDE EFFECTS Source text: ID:nGNX5HPCNL Further company coverage: BDPT.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioAdaptives
See all newsBrief: Bioadaptives Says Successful Completion Of Dosage Trials For Its Innovative Weight Loss Product, Zeranovia
Brief: BioAdaptives Announces Spin-off LiveStock Impact Division as Wholly Owned Subsidiary
Brief: Bioadaptives Inc Announces Intention To Spin Off Its Livestock Impact Division As A Wholly-Owned Subsidiary
Brief: Bioadaptives Signs Non-Exclusive License With Ly Research To Market Patented Bioavailable Resveratrol For Both Animals And Humans
Brief: Bioadaptives Inc. Reports New Appointment To The Board Of Directors - Visionary Futurist , Wellness Pioneer And Marketer, David Allen, Phd